Eversense Implantable CGM
Eversense®, the only FDA-approved, implantable CGM
Easily manage your diabetes with confidence
Eversense® E3 CGM from Senseonics
With the Eversense 180-day CGM system, you can easily manage your diabetes with confidence. Eversense provides continuous blood glucose monitoring for up to 180 days via an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.
No other CGM system gives you this much wear time, and you only have to change the sensor two times a year! Eversense is the only CGM with on-body vibrations to alert you to potentially dangerous swings in blood sugar, which is great when you’re sleeping, driving, or unable to check your phone. Contact us to learn more!
Sensor is inserted by a physician and rests just under the skin
Only CGM with on-body vibration alerts when receiver is not nearby
Rechargeable, removable, and water resistant*
Share your data with your friends, family, and healthcare provider
———- Discover More ———-
How it Works
Learn More about Eversense E3 CGM
Eversense E3 provides continuous blood glucose monitoring for up to 180 days via an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.
The transmitter sends data every 5 minutes to your mobile device, and provides on-body alerts so you don’t always have to have your mobile device nearby.
The transmitter is water resistant when submerged in 1 meter of water for up to 30 minutes.
Yes. The Eversense app receives and displays data in easy-to-read charts and graphs. No need to carry a separate receiver. Instead, you can discreetly check your info on a compatible Android™ or iOS smartphone or Apple Watch.®
*Water resistant when submerged in 1 meter of water for up to 30 minutes.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more. For safety information click here.
Eversense, Eversense E3 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, and the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.